Johnson & Johnson is reviewing its bank lines in connection with back-to-back acquisition agreements totaling nearly $2 billion.

In its latest deal, the New Brunswick, N.J., health-care giant said Tuesday that it agreed to buy Eastman Kodak Co.'s clinical diagnostics business for $1 billion in cash.

Subscribe Now

Access to authoritative analysis and perspective and our data-driven report series.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.